Haleon (HLN) Dividends Paid - Common (2021 - 2023)
Haleon (HLN) posted Dividends Paid - Common of -$275.5 million for Q4 2023, up 73.09% on a QoQ basis from -$1.0 billion in Q4 2022, and up 73.09% year-over-year from -$159.2 million in Q4 2022.
Haleon (HLN) Dividends Paid - Common (2021 - 2023) Analysis & Trends
Haleon's Dividends Paid - Common history runs 3 years deep, the most recent figure standing at -$275.5 million for Q4 2023.
- Quarterly Dividends Paid - Common rose 73.09% year-over-year to -$275.5 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was -$3.2 billion (changed N/A YoY) and the FY2025 annual result came in at $806.9 million, up 10.75% from the prior year.
- Dividends Paid - Common was -$275.5 million for Q4 2023 at Haleon, up from -$1.0 billion in the prior quarter.
- Across five years, Dividends Paid - Common topped out at -$275.5 million in Q4 2023 and bottomed at -$1.1 billion in Q3 2022.
- A 3-year average of -$802.9 million and a median of -$930.5 million in 2021 frame the typical range for Dividends Paid - Common.
- Annual changes were most pronounced in 2022 — Dividends Paid - Common retreated 22.32% — and 2023, when it surged 73.09%.
- Haleon's Dividends Paid - Common stood at -$837.1 million in 2021, then retreated by 22.32% to -$1.0 billion in 2022, then jumped by 73.09% to -$275.5 million in 2023.
- Business Quant data shows HLN's Dividends Paid - Common at -$275.5 million in Q4 2023, -$1.0 billion in Q4 2022, and -$1.1 billion in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 224.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.92 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 139.60 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -275.54 Mn |
| Dec 31, 2023 | -275.54 Mn |
| Dec 31, 2022 | -1.02 Bn |
| Dec 31, 2022 | -1.02 Bn |
| Sep 20, 2022 | -1.07 Bn |
| Sep 20, 2022 | -1.07 Bn |
| Dec 31, 2021 | -837.11 Mn |
| Dec 31, 2021 | -837.11 Mn |